0001012975-20-000580.txt : 20200625 0001012975-20-000580.hdr.sgml : 20200625 20200625192116 ACCESSION NUMBER: 0001012975-20-000580 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200625 FILED AS OF DATE: 20200625 DATE AS OF CHANGE: 20200625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pivotal bioVenture Partners Fund I, L.P. CENTRAL INDEX KEY: 0001695076 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39343 FILM NUMBER: 20990570 BUSINESS ADDRESS: STREET 1: 501 SECOND STREET, SUITE 200 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: (345) 949 1040 MAIL ADDRESS: STREET 1: 501 SECOND STREET, SUITE 200 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 FORMER NAME: FORMER CONFORMED NAME: Pivotal Venture Partners Fund I, L.P. DATE OF NAME CHANGE: 20170118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pivotal bioVenture Partners Fund I G.P., L.P. CENTRAL INDEX KEY: 0001752862 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39343 FILM NUMBER: 20990571 BUSINESS ADDRESS: STREET 1: 501 SECOND STREET, SUITE 200 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: (415) 697-1002 MAIL ADDRESS: STREET 1: 501 SECOND STREET, SUITE 200 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akouos, Inc. CENTRAL INDEX KEY: 0001722271 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 645 SUMMER STREET, SUITE 200 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-245-5715 MAIL ADDRESS: STREET 1: 645 SUMMER STREET, SUITE 200 CITY: BOSTON STATE: MA ZIP: 02210 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2020-06-25 0 0001722271 Akouos, Inc. AKUS 0001695076 Pivotal bioVenture Partners Fund I, L.P. 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107 0 0 1 0 0001752862 Pivotal bioVenture Partners Fund I G.P., L.P. 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107 0 0 1 0 Series B Preferred Stock Common Stock 1499971 I See footnote The Series B Preferred Stock is convertible into Common Stock on a 21.073-for-1 basis into the number of shares of Common Stock as shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date. The reportable securities are owned directly by Pivotal bioVenture Partners Fund I, L.P. ("Pivotal"). The general partner of Pivotal is Pivotal bioVenture Partners Fund I G.P., L.P., or Pivotal GP. Robert Hopfner, Vincent Cheung, Peter Bisgaard, and Heather Preston are the managing partners of Pivotal and may be deemed to have shared voting and dispositive power over the shares owned by Pivotal. /s/ Heather Preston, MD - for Pivotal bioVenture Partners Fund I, L.P., as Managing Partner 2020-06-25 /s/ Heather Preston, MD - for Pivotal bioVenture Partners Fund I G.P., L.P., as Managing Partner 2020-06-25